Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CO2-enriched air and nebulizer comparison for inhaled tobramycin deposition in bronchiectasis
NL-OMON25652Completed
- Sponsor
- Vrije University Medical Center
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of tobramycin in bronchiectasis (3 arms), sponsored by Vrije University Medical Center. Primary endpoints: Feasibility of SPECT/CT scans, Pulmonary deposition and 1 more. Started Aug 2013; status: completed.
02
Drugs
tobramycin
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on NL-OMON25652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON25652.